Adverse reactions associated with penicillins, carbapenems, monobactams, and clindamycin: A retrospective population-based study.
Limited population-based data on penicillin-, carbapenem-, monobactam-, and clindamycin-associated reported adverse reactions exists. Collect data on penicillin, carbapenem, monobactam, and clindamycin usage and associated adverse reactions. Data from 1-1-2009 to 12-31-2017 in Kaiser Permanente Southern California was collected. There were 6,144,422 unique individuals, mean age 33.6 ± 21.1 years, 52.2% females, with at least one healthcare visit during the 9-year study interval, for a total of 37,387,313 patient-years of follow-up. This population was exposed to 5,617,402 courses of oral penicillins, 370,478 courses of parenteral penicillins, 59,645 courses of parenteral carbapenems or monobactams, 817,232 courses of oral clindamycin, and 215,880 courses of parenteral clindamycin. New penicillin allergies were reported more commonly after parenteral (0.85%) compared to oral (0.74%) exposures (p<0.0001). There were 22 cases (1 in 255,320) of oral penicillin-associated anaphylaxis and 3 cases (1 in 123,792) of parenteral penicillin-associated anaphylaxis (p < 0.001). There were 2 clindamycin-associated anaphylaxis cases, 1 (1 in 817,232) oral and 1 (1 in 215,880) parenteral. There were 2 (1 in 2,993,940) penicillin-associated SCAR cases, but both also had co-trimoxazole co-exposure within 45 days. There was 1 (1 in 1,033,112) clindamycin-associated SCAR. Clostridioides difficile infection was more common after parenteral exposures, and with extended-spectrum penicillins, beta lactamase combinations, carbapenems, monobactam, and clindamycin exposures compared to oral penicillins or clindamycin. Only 1/1543 (0.065%) oral and 1/1030 (0.097%) parenteral penicillin-associated allergy reports were confirmed to be anaphylaxis. Clostridioides difficile was more common after parenteral versus oral penicillin, carbapenem, monobactam, and clindamycin exposures, and with broader spectrum antibiotic exposures.